Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease

被引:0
|
作者
Jeong Woo Kim
Young-Sun Lee
Yang Shin Park
Baek-Hui Kim
Soo Yeon Lee
Jong Eun Yeon
Chang Hee Lee
机构
[1] Korea University Guro Hospital,Department of Radiology
[2] Korea University College of Medicine,Department of Radiology
[3] Korean Armed Forces Capital Hospital,Department of Internal Medicine
[4] Korea University Guro Hospital,Department of Pathology
[5] Korea University College of Medicine,undefined
[6] Korea University Guro Hospital,undefined
[7] Korea University College of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic steatohepatitis (NASH) is a complex disease consisting of various components including steatosis, lobular inflammation, and ballooning degeneration, with or without fibrosis. Therefore, it is difficult to diagnose NASH with only one imaging modality. This study was aimed to evaluate the feasibility of magnetic resonance imaging (MRI) for predicting NASH and to develop a non-invasive multiparametric MR index for the detection of NASH in non-alcoholic fatty liver disease (NAFLD) patients. This prospective study included 47 NAFLD patients who were scheduled to undergo or underwent ultrasound-guided liver biopsy within 2 months. Biopsy specimens were graded as NASH or non-NASH. All patients underwent non-enhanced MRI including MR spectroscopy (MRS), MR elastography (MRE), and T1 mapping. Diagnostic performances of MRS, MRE, and T1 mapping for grading steatosis, activity, and fibrosis were evaluated. A multiparametric MR index combining fat fraction (FF), liver stiffness (LS) value, and T1 relaxation time was developed using linear regression analysis. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of the newly devised MR index. Twenty NASH patients and 27 non-NASH patients were included. Using MRS, MRE, and T1 mapping, the mean areas under the curve (AUCs) for grading steatosis, fibrosis, and activity were 0.870, 0.951, and 0.664, respectively. The multiparametric MR index was determined as 0.037 × FF (%) + 1.4 × LS value (kPa) + 0.004 × T1 relaxation time (msec) −3.819. ROC curve analysis of the MR index revealed an AUC of 0.883. The cut-off value of 6 had a sensitivity of 80.0% and specificity of 85.2%. The multiparametric MR index combining FF, LS value, and T1 relaxation time showed high diagnostic performance for detecting NASH in NAFLD patients.
引用
收藏
相关论文
共 50 条
  • [41] Is elevated aminotransferase levels a prerequisite to suspect non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease?
    Amin, M. A.
    Gabr, H. M.
    EL-Hindawy, A.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S191 - S192
  • [42] Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis
    Le, Thuy-Anh
    Loomba, Rohit
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (02) : 156 - 173
  • [43] Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
    Lirussi, F.
    Mastropaqua, E.
    Orando, S.
    Orlando, R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [44] VALIDATION OF A NOVEL BIOMARKER MODEL FOR THE PREDICTION OF NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Tanwar, Sudeep
    Trembling, Paul M.
    Guha, Indra Neil
    Parkes, Julie
    Kaye, Philip
    Burt, Alastair D.
    Ryder, Stephen D.
    Aithal, Guruprasad P.
    Day, Christopher P.
    Rosenberg, William M.
    HEPATOLOGY, 2011, 54 : 1123A - 1123A
  • [45] SAROGLITAZAR MAGNESIUM IMPROVES LIPID PARAMETERS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE / NON-ALCOHOLIC STEATOHEPATITIS
    Parmar, D.
    Gawrieh, S.
    Cusi, K.
    Chalasani, N.
    Cisneros Garza, L. Esthela
    Bihari, C.
    Cruz Lopez, J. L. Pio
    Bainbridge, J.
    Vellanki, R.
    Shaikh, F.
    Jain, P.
    Maroo, S.
    Manjunath, K.
    Parmar, K.
    Patil, K.
    ATHEROSCLEROSIS, 2020, 315 : E47 - E47
  • [46] Prevalence of non-alcoholic steatohepatitis in patients undergoing laparoscopic cholecystectomy for gallstone with non-alcoholic fatty liver disease
    Anand, Utpal
    John, Aaron
    Kumar, Ramesh
    Priyadarshi, Rajeev
    JOURNAL OF HEPATOLOGY, 2022, 77 : S170 - S171
  • [47] THE PATHOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE CORRELATES WITH GUT MICROBIOTA COMPOSITION IN MICE: FROM NON-ALCOHOLIC FATTY LIVER TO NON-ALCOHOLIC STEATOHEPATITIS
    Peng, J.
    Huang, F.
    Li, X.
    Chen, L.
    Feng, Q.
    Hu, Y.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S155 - S157
  • [48] The diagnosis of non-alcoholic fatty liver disease
    Wlazlo, N.
    van Greevenbroek, M. M. J.
    Ferreira, I.
    Bravenboer, B.
    Stehouwer, C. D. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (01) : 204 - 205
  • [49] Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease
    Tannapfel, A.
    Denk, H.
    Dienes, H. P.
    Langner, C.
    Schirmacher, P.
    Trauner, M.
    Flott-Rahmel, B.
    PATHOLOGE, 2010, 31 (03): : 225 - 237
  • [50] Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease
    Tannapfel, Andrea
    Denk, Helmut
    Dienes, Hans-Peter
    Langner, Cord
    Schirmacher, Peter
    Trauner, Michael
    Flott-Rahmel, Berenike
    VIRCHOWS ARCHIV, 2011, 458 (05) : 511 - 523